1fwb Citations

Structures of Cys319 variants and acetohydroxamate-inhibited Klebsiella aerogenes urease.

Biochemistry 36 8164-72 (1997)
Related entries: 1fwa, 1fwc, 1fwd, 1fwe, 1fwf, 1fwg, 1fwh, 1fwj, 1kra, 1krb, 1krc, 2kau

Cited: 60 times
EuropePMC logo PMID: 9201965

Abstract

Cys319 is located on a mobile flap covering the active site of Klebsiella aerogenes urease but does not play an essential role in catalysis. Four urease variants altered at position C319 range from having high activity (C319A) to no measurable activity (C319Y), indicating Cys is not required at this position, but its presence is highly influential [Martin, P. R., & Hausinger, R. P. (1992) J. Biol. Chem. 267, 20024-20027]. Here, we present 2.0 A resolution crystal structures of C319A, C319S, C319D, and C319Y proteins and the C319A variant inhibited by acetohydroxamic acid. These structures show changes in the hydration of the active site nickel ions and in the position and flexibility of the active site flap. The C319Y protein exhibits an alternate conformation of the flap, explaining its lack of activity. The changes in hydration and conformation suggest that there are suboptimal protein-solvent and protein-protein interactions in the empty urease active site which contribute to urease catalysis. Specifically, we hypothesize that the suboptimal interactions may provide a significant source of substrate binding energy, and such hidden energy may be a common phenomenon for enzymes that contain mobile active site loops and undergo an induced fit. The acetohydroxamic acid-bound structure reveals a chelate interaction similar to those seen in other metalloenzymes and in a small molecule nickel complex. The inhibitor binding mode supports the proposed mode of urea binding. We complement these structural studies with extended functional studies of C319A urease to show that it has enhanced stability and resistance to inhibition by buffers containing nickel ions. The near wild-type activity and enhanced stability of the C319A variant make it useful for further studies of urease structure-function relationships.

Reviews - 1fwb mentioned but not cited (1)

  1. Nonredox nickel enzymes. Maroney MJ, Ciurli S. Chem Rev 114 4206-4228 (2014)


Reviews citing this publication (13)

  1. Divergent evolution of enzymatic function: mechanistically diverse superfamilies and functionally distinct suprafamilies. Gerlt JA, Babbitt PC. Annu Rev Biochem 70 209-246 (2001)
  2. Nickel uptake and utilization by microorganisms. Mulrooney SB, Hausinger RP. FEMS Microbiol Rev 27 239-261 (2003)
  3. Nickel-dependent metalloenzymes. Boer JL, Mulrooney SB, Hausinger RP. Arch Biochem Biophys 544 142-152 (2014)
  4. Interplay of metal ions and urease. Carter EL, Flugga N, Boer JL, Mulrooney SB, Hausinger RP. Metallomics 1 207-221 (2009)
  5. Biosynthesis of the urease metallocenter. Farrugia MA, Macomber L, Hausinger RP. J Biol Chem 288 13178-13185 (2013)
  6. Structure/function relationships in nickel metallobiochemistry. Maroney MJ. Curr Opin Chem Biol 3 188-199 (1999)
  7. Active sites of transition-metal enzymes with a focus on nickel. Ermler U, Grabarse W, Shima S, Goubeaud M, Thauer RK. Curr Opin Struct Biol 8 749-758 (1998)
  8. Insights into the role and structure of plant ureases. Follmer C. Phytochemistry 69 18-28 (2008)
  9. Nickel biochemistry. Ragsdale SW. Curr Opin Chem Biol 2 208-215 (1998)
  10. Quantum mechanical and molecular dynamics simulations of ureases and Zn beta-lactamases. Estiu G, Suárez D, Merz KM. J Comput Chem 27 1240-1262 (2006)
  11. Recent advances in design of new urease inhibitors: A review. Kafarski P, Talma M. J Adv Res 13 101-112 (2018)
  12. The structure-based reaction mechanism of urease, a nickel dependent enzyme: tale of a long debate. Mazzei L, Musiani F, Ciurli S. J Biol Inorg Chem 25 829-845 (2020)
  13. The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications. Miri AH, Kamankesh M, Llopis-Lorente A, Liu C, Wacker MG, Haririan I, Asadzadeh Aghdaei H, Hamblin MR, Yadegar A, Rad-Malekshahi M, Zali MR. Front Pharmacol 13 917184 (2022)

Articles citing this publication (46)



Related citations provided by authors (4)